Evidence map›Paper›PMID 41109265›Full record

Trial reportThe Lancet. Global health2025

When are postpartum haemorrhages diagnosed? A nested observational study within the E-MOTIVE cluster-randomised trial.

Kristie-Marie Mammoliti, James Martin, Adam Devall, Christina Easter, Fernando Althabe, Adeosun Love Funmi, Rahmatu Yusuf, Fatima Abubakar, Lolade Christiana Arigbede, Jim Kelly Mugambi and 23 more

Registry-linked trialAbstract readObservational StudyRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in The Lancet. Global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04341662 (Early Detection of Postpartum Haemorrhage and Treatment Using the World Health Organisation MOTIVE 'First Response' Bundle), which is not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04341662 nacompletednot on this map

Early Detection of Postpartum Haemorrhage and Treatment Using the World Health Organisation MOTIVE 'First Response' Bundle: a Cluster Randomised Trial With Health Economic Analysis and Mixed-methods Evaluation (E-MOTIVE Trial)

TypeinterventionalSponsorUniversity of BirminghamRan2020 to 2023Enrolled99,659ConditionsPost-Partum HaemorrhageArmsE-MOTIVE intervention, Usual care
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Kristie-Marie MammolitiCollege of Medicine and Health, University of Birmingham, Birmingham, UK. Electronic address: kmammoliti@unimelb.edu.au.
James MartinCollege of Medicine and Health, University of Birmingham, Birmingham, UK.
Adam DevallCollege of Medicine and Health, University of Birmingham, Birmingham, UK.
Christina EasterCollege of Medicine and Health, University of Birmingham, Birmingham, UK.
Fernando AlthabeUNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development, and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Adeosun Love FunmiAfrican Center of Excellence for Population Health and Policy, College of Health Sciences, Bayero University, Kano, Nigeria.
Rahmatu YusufAfrican Center of Excellence for Population Health and Policy, College of Health Sciences, Bayero University, Kano, Nigeria.
Fatima AbubakarAfrican Center of Excellence for Population Health and Policy, College of Health Sciences, Bayero University, Kano, Nigeria.
Lolade Christiana ArigbedeAfrican Center of Excellence for Population Health and Policy, College of Health Sciences, Bayero University, Kano, Nigeria.
Jim Kelly MugambiDepartment of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya.
Polycarp OyooDepartment of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya.
Masumbuko SambusaDepartment of Obstetrics and Gynecology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Akwinata BandaDepartment of Obstetrics and Gynecology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Fawzia SamuelsDepartment of Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa.
Sara WillemseDepartment of Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa.
Sibongile Doris KhambuleEffective Care Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Walter Sisulu University, Mthatha, South Africa.
Hilal Mukhtar Shu'aibAfrican Center of Excellence for Population Health and Policy, College of Health Sciences, Bayero University, Kano, Nigeria.
Aminu Ado WakiliAfrican Center of Excellence for Population Health and Policy, College of Health Sciences, Bayero University, Kano, Nigeria.
Jenipher OkoreDepartment of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya.
Ard MwampashiDepartment of Obstetrics and Gynecology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Mandisa Singata-MadlikiEffective Care Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Walter Sisulu University, Mthatha, South Africa.
Edna ArendsDepartment of Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa.
Elani MullerEffective Care Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Hadiza GaladanciAfrican Center of Excellence for Population Health and Policy, College of Health Sciences, Bayero University, Kano, Nigeria.
Zahida QureshiDepartment of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya.
Fadhlun Alwy Al-BeityDepartment of Obstetrics and Gynecology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
G Justus HofmeyrEffective Care Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Walter Sisulu University, Mthatha, South Africa; Department of Obstetrics and Gynecology, University of Botswana, Gaborone, Botswana.
Sue FawcusDepartment of Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa.
Neil MoranKwaZulu-Natal Department of Health, Pietermaritzburg, South Africa; Department of Obstetrics and Gynaecology, Nelson Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Alfred OsotiDepartment of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya.
George GwakoDepartment of Obstetrics and Gynecology, University of Nairobi, Nairobi, Kenya.
Ioannis GallosUNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development, and Research Training in Human Reproduction, Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Arri CoomarasamyNuffield Department of Women's and Reproductive Health, John Radcliffe Hospital, University of Oxford, Oxford, UK.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe definition of primary postpartum haemorrhage as blood loss of 500 mL or more within 24 h after vaginal birth underemphasises the early postpartum hours due to limited data on the timing of postpartum haemorrhage diagnosis. Understanding postpartum haemorrhage diagnosis timing and diagnostic methods is important for guiding diagnostic and therapeutic strategies. The E-MOTIVE trial evaluated early postpartum haemorrhage diagnosis and a bundled treatment approach, which resulted in a 60% relative reduction in adverse outcomes from bleeding compared with usual care. We aimed to compare timing from vaginal birth to postpartum haemorrhage diagnosis and the diagnostic methods used among four African countries implementing the intervention from the E-MOTIVE trial.

methodsNested within the E-MOTIVE trial (NCT04341662), we conducted direct observations of health-care workers providing clinical care to postpartum women at 39 hospitals implementing the E-MOTIVE intervention across Nigeria, Kenya, Tanzania, and South Africa. One to two weeks of continuous observations were conducted from vaginal birth up to 2 h, between June 27, and Dec 18, 2022. Health-care workers were trained to use clinical judgement (ie, heavy vaginal blood loss, large blood clots expelled, or constant trickle) and various objective blood loss thresholds to diagnose postpartum haemorrhage. The objective blood loss thresholds used in Nigeria, Kenya, and Tanzania were 300 mL or more with at least one abnormal clinical sign (ie, pulse, blood pressure, uterine tone, and vaginal blood flow) or 500 mL or more. The objective blood loss threshold in South Africa was 500 mL or more. We descriptively analysed and compared timing from vaginal birth to postpartum haemorrhage diagnosis and diagnostic methods used between countries.

findingsOf 2578 women, 295 postpartum haemorrhages were diagnosed. The median time from vaginal birth to postpartum haemorrhage diagnosis was 15 min in Nigeria and Tanzania, 17 min in Kenya, and 30 min in South Africa. Diagnosis within 30 min ranged from 58% in South Africa to 86% in Tanzania. By 60 min, 96% to 100% of postpartum haemorrhages were diagnosed across all countries. All postpartum haemorrhages that required an intervention were diagnosed within 90 min. Nigeria, Kenya, and Tanzania commonly used blood loss of 300 mL or more combined with at least one abnormal clinical sign (47%, 65%, and 68%, respectively) while South Africa relied on a definition of 500 mL or more (81%) as the dominant diagnostic strategy.

interpretationIn countries where an objective blood loss threshold of 300 mL or more with at least one abnormal clinical sign was used, women received earlier interventions for postpartum bleeding, with a median time to diagnosis of 15-17 min. This was notably faster than in the country that predominantly used a 500 mL or more threshold, where the median time to diagnosis was 30 min. Regardless of whether the threshold was 300 mL or more with abnormal clinical signs or 500 mL or more alone, all postpartum haemorrhages were diagnosed within 90 min of vaginal birth.

fundingBill & Melinda Gates Foundation and Ammalife.

Indexed as

Postpartum HemorrhageAdultFemaleHumansKenyaPregnancyTanzaniaTime FactorsYoung Adult

Identifiers

PMID41109265
PMCPMC12535819

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.